APOL1-IN-1
APOL1-IN-1 is a apolipoprotein L1 (APOL1) inhibitor extracted from patent WO2020131807A1 compound 87. APOL1-IN-1 can be used for the research of focal segmental glomerulosclerosis (FSGS) and non-diabetic kidney disease (NDKD) [1].
Product Specifications
CAS Number
[2446817-72-5]
UNSPSC
12352005
Target
Apolipoprotein
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/apol1-in-1.html
Purity
99.85
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(N[C@@H]1C(NC[C@H]1O)=O)CCC2=C(C3=CC=C(F)C=C3)NC4=C2C=CC=C4
Molecular Formula
C21H20FN3O3
Molecular Weight
381.40
References & Citations
[1]Brodney M, et, al. Inhibitors of apol1 and methods of using same. WO2020131807A1.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15301047 1 Vial
Lentiviral mouse Plac8l1 shRNA (UAS) - Lentiviral mouse Plac8l1 shRNA (UAS, RFP) (100)
Ask
View Details 
